Trial · NCT03629418
Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery
NCT03629418, Not applicable, Recruiting, Peking University First Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery. Trials, record NCT03629418. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03629418
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery
- NCT number
- NCT03629418
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 612 participants, estimated
- Lead sponsor
- Peking University First Hospital
- Conditions
- Coronary Artery Bypass, Off-Pump, Intraoperative Hypotension, Acute Kidney Injury, Preventive Medicine, Intraoperative Care
- Interventions
- Targeted blood-pressure management, Routine blood-pressure management
- First posted
- 2018-08-14
- Last updated
- 2025-07-30
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of acute kidney injury (AKI) within 7 days after surgery | Up to 7 days after surgery | Development of AKI within 7 days after surgery is diagnosed according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria |
| Secondary | Classification of AKI within 7 days after surgery | Up to 7 days after surgery | Development of AKI within 7 days after surgery is diagnosed according to the KDIGO criteria |
| Secondary | Incidence of delirium within 7 days after surgery | Up to 7 days after surgery | Development of delirium within 7 days after surgery is assessed with the Confusion Assessment Method (3D-CAM for patients without mechanical ventilation and CAM-ICU for patients with mechanical ventilation). |
| Secondary | Duration of mechanical ventilation after surgery | Up to 30 days after surgery | Duration of mechanical ventilation after surgery |
| Secondary | Length of stay in intensive care unit (ICU) after surgery | Up to 30 days after surgery | Length of stay in intensive care unit (ICU) after surgery |
| Secondary | Length of stay in hospital after surgery | Up to 30 days after surgery | Length of stay in hospital after surgery |
| Secondary | Incidence of major adverse cardiovascular events (MACEs) within 30 days after surgery | Up to 30 days after surgery | MACEs within 30 days after surgery include cardiovascular death, non-fatal cardiac arrest, acute myocardial infarction, revascularization, and stroke. |
| Secondary | Incidence of non-MACE complications within 30 days after surgery | Up to 30 days after surgery | Non-MACE complications within 30 days after surgery indicate new-onset medical conditions other than MACEs that produce harmful effects on patients' recovery and required therapeutic intervention. |
| Secondary | All-cause 30-day mortality | At 30 days after surgery | All-cause 30-day mortality |
| Secondary | 2-year overall survival after surgery | Up to 2 years after surgery | 2-year overall survival after surgery |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers16
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03629418
GET https://conductscience.org/api/trials/v1/NCT03629418/registered